Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • US Patent Issued to Brookhaven Lab, BioSet

Photonics Spectra
May 2009
Brookhaven Science Associates, which operates and manages the US Department of Energy’s Brookhaven National Laboratory, and Biosurface Engineering Technologies Inc. (BioSet) have been issued a US patent for a synthetic peptide called B2A. A medical device called Amplex has been developed that incorporates B2A osteoinductive growth factor with an ultrahigh-grade ceramic bone substitute for use in surgery. The FDA has approved a pilot study of 22 patients by BioSet to evaluate the safety and preliminary efficacy of the device.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!